Origin and significance of leucine-rich glioma-inactivated 1 antibodies in cerebrospinal fluid
Neurological Sciences · 2024
DOI: 10.1007/s10072-024-07489-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurological Sciences, 2024. Verfasst von Fang Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, First Hospital of Shanxi Medical University, Taiyuan, China. Hauptthemen laut MEDLINE: Autoantibodies, Intracellular Signaling Peptides and Proteins. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, First Hospital of Shanxi Medical University, Taiyuan, China.
- Department of Neurology, The Second People's Hospital of Lianyungang, Lianyungang, China.
- Department of Neurology, First Hospital of Shanxi Medical University, Taiyuan, China. luwanglu2012@163.com.
Zitieren
APA
Zhang, F., Zhou, H., Yi, Y., Li, N., Liu, M., Shen, H., Guo, Y., & Wang, J. (2024). Origin and significance of leucine-rich glioma-inactivated 1 antibodies in cerebrospinal fluid. Neurological Sciences. https://doi.org/10.1007/s10072-024-07489-6
Vancouver
Zhang F, Zhou H, Yi Y, Li N, Liu M, Shen H, et al. Origin and significance of leucine-rich glioma-inactivated 1 antibodies in cerebrospinal fluid. Neurological Sciences. 2024. doi:10.1007/s10072-024-07489-6
BibTeX
@article{Zhang2024,
author = {Zhang, Fang and Zhou, Hong and Yi, Yujie and Li, Na and Liu, Miaomiao and Shen, Huijun and Guo, Yingshi and Wang, Jie},
title = {Origin and significance of leucine-rich glioma-inactivated 1 antibodies in cerebrospinal fluid},
journal = {Neurological Sciences},
year = {2024},
doi = {10.1007/s10072-024-07489-6}
}
EUVIMED